CDK4 Cancer Research Results
CDK4, Cyclin-dependent kinase 4: Click to Expand ⟱
| Source: |
| Type: |
Cyclin-dependent kinase 4 (CDK4) is a key regulator of the cell cycle, particularly in the transition from the G1 phase to the S phase. Its expression and activity are often altered in various cancers, contributing to tumorigenesis.
CDK4 is frequently overexpressed in various cancers, and its expression levels can serve as a prognostic marker.
|
Park, Parkinson's Disease (PD): Click to Expand ⟱
Parkinson's disease (PD) is a neurodegenerative disorder characterized by motor and non-motor symptoms, and is due to the degeneration of dopaminergic neurons. It is multifactorial, caused by genetic and environmental factors and currently has no definitive cure.
-CoQ10 deficiency was observed at a higher frequency in Parkinson's disease
|
Scientific Papers found: Click to Expand⟱
| - |
Review, |
Var, |
NA |
|
|
|
- |
Review, |
Stroke, |
NA |
|
|
|
- |
Review, |
Diabetic, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
*antiOx↑, *AntiCan↑, *AntiDiabetic↑, *cardioP↑, *Obesity↓, *hepatoP↑, *AntiAg↑, *Bacteria↓, *Imm↑, MMP2↓, MMP9↓, Apoptosis↓, MMP↓, ERK↓, PI3K↓, ALAT↓, *ROS↓, *Catalase↑, *SOD↑, *GPx↑, *AST↓, *LDH↓, *necrosis↓, ROS↑, TumCCA↑, CDK4↓, cycD1/CCND1↓, NOTCH↓, IL6↓, chemoP↑, *Pain↓, *neuroP↑, *TRPM7↓, *motorD↑, *NF-kB↓, *COX2↓, *MDA↓,
| - |
Review, |
Var, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
*Inflam↓, *antiOx↑, *neuroP↑, *IL6↓, *IL1β↓, *NF-kB↓, *PGE2↓, *COX2↓, *MMP↑, *memory↑, *ROS↓, *Aβ↓, *HMGB1↓, TumCG↓, MARK4↓, Zeb1↓, MDM2↓, BNIP3↑, ASC↑, NLRP3↓, PI3K↓, Akt↓, Casp1↓, E-cadherin↑, STAT3↓, TLR4↓, MMP↓, ICAM-1↓, AMPK↓, IL6↑, MMP2↓, Warburg↓, Bcl-xL↓, Bcl-2↓, TumCCA↑, EMT↓, TumMeta↓, mTOR↓, HSP27↓, Casp3↑, GlucoseCon↓, lactateProd↓, VEGF↓, p‑p65↓, GIT1↓, FOXM1↓, cycD1/CCND1↓, CDK4↓, MMP9↓, HDAC2↓,
Showing Research Papers: 1 to 2 of 2
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 2
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
ROS↑, 1,
Mitochondria & Bioenergetics ⓘ
MMP↓, 2,
Core Metabolism/Glycolysis ⓘ
ALAT↓, 1, AMPK↓, 1, GlucoseCon↓, 1, lactateProd↓, 1, Warburg↓, 1,
Cell Death ⓘ
Akt↓, 1, Apoptosis↓, 1, Bcl-2↓, 1, Bcl-xL↓, 1, Casp1↓, 1, Casp3↑, 1, MDM2↓, 1,
Protein Folding & ER Stress ⓘ
HSP27↓, 1,
Autophagy & Lysosomes ⓘ
BNIP3↑, 1,
Cell Cycle & Senescence ⓘ
CDK4↓, 2, cycD1/CCND1↓, 2, TumCCA↑, 2,
Proliferation, Differentiation & Cell State ⓘ
EMT↓, 1, ERK↓, 1, FOXM1↓, 1, HDAC2↓, 1, mTOR↓, 1, NOTCH↓, 1, PI3K↓, 2, STAT3↓, 1, TumCG↓, 1,
Migration ⓘ
E-cadherin↑, 1, GIT1↓, 1, MARK4↓, 1, MMP2↓, 2, MMP9↓, 2, TumMeta↓, 1, Zeb1↓, 1,
Angiogenesis & Vasculature ⓘ
VEGF↓, 1,
Immune & Inflammatory Signaling ⓘ
ASC↑, 1, ICAM-1↓, 1, IL6↓, 1, IL6↑, 1, p‑p65↓, 1, TLR4↓, 1,
Protein Aggregation ⓘ
NLRP3↓, 1,
Clinical Biomarkers ⓘ
ALAT↓, 1, FOXM1↓, 1, IL6↓, 1, IL6↑, 1,
Functional Outcomes ⓘ
chemoP↑, 1,
Total Targets: 48
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
antiOx↑, 2, Catalase↑, 1, GPx↑, 1, MDA↓, 1, ROS↓, 2, SOD↑, 1,
Mitochondria & Bioenergetics ⓘ
MMP↑, 1,
Core Metabolism/Glycolysis ⓘ
LDH↓, 1,
Cell Death ⓘ
necrosis↓, 1,
Proliferation, Differentiation & Cell State ⓘ
TRPM7↓, 1,
Migration ⓘ
AntiAg↑, 1,
Immune & Inflammatory Signaling ⓘ
COX2↓, 2, HMGB1↓, 1, IL1β↓, 1, IL6↓, 1, Imm↑, 1, Inflam↓, 1, NF-kB↓, 2, PGE2↓, 1,
Protein Aggregation ⓘ
Aβ↓, 1,
Clinical Biomarkers ⓘ
AST↓, 1, IL6↓, 1, LDH↓, 1,
Functional Outcomes ⓘ
AntiCan↑, 1, AntiDiabetic↑, 1, cardioP↑, 1, hepatoP↑, 1, memory↑, 1, motorD↑, 1, neuroP↑, 2, Obesity↓, 1, Pain↓, 1,
Infection & Microbiome ⓘ
Bacteria↓, 1,
Total Targets: 33
Scientific Paper Hit Count for: CDK4, Cyclin-dependent kinase 4
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:75 Cells:% prod#:% Target#:894 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page